Inspire Medical Systems, Inc. with ticker code (INSP) now have 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $265.00 and $181.00 suggesting an average analyst share price target price of $229.58. (at the time of writing). Now with the previous closing price of $193.31 and the analysts are correct then we can expect a percentage increase in value of 18.8%. The 50 day MA is $167.30 and the 200 day MA is $230.13. The market cap for the company is 5.80B. The current share price for the company is: $196.42 USD
The potential market cap would be $6,887,214,046 based on the market consensus.
The company has a dividend yield of 2.05%. Other points of data to note are a P/E ratio of -, revenue per share of $19.56 and a -5.35% return on assets.
Inspirit Energy Holdings PLC is a United Kingdom-based developer of micro-Combined Heat and Power (microCHP) boilers. The principal activity of the Company is that of an investment company that focuses on investing in disruptive products or technologies that are either proven or at the later stages of development, which own or have exclusive license to the relevant intellectual property. It also applies its expertise in the application of the Stirling engine technology in different sectors, including marine and waste heat recovery. It is also engaged in the development and commercialization of a microCHP boiler for use in commercial and residential markets. The microCHP boiler is powered by natural gas or hydrogen and designed to produce hot water (for domestic hot water or central heating) and a simultaneous electrical output that can be used locally or fed back into the national grid. Its Inspirit Charger can be installed as a standalone, or as the lead appliance in a plant room.
